Cochrane Abstracts
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neoadjuvant and Adjuvant Therapy for Surgical Resection of Hepatocellular Carcinoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432298/all/Neoadjuvant_and_adjuvant_therapy_for_surgical_resection_of_hepatocellular_carcinoma.
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432298/all/Neoadjuvant_and_adjuvant_therapy_for_surgical_resection_of_hepatocellular_carcinoma. Accessed January 20, 2026.
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432298/all/Neoadjuvant_and_adjuvant_therapy_for_surgical_resection_of_hepatocellular_carcinoma
Neoadjuvant and Adjuvant Therapy for Surgical Resection of Hepatocellular Carcinoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432298/all/Neoadjuvant_and_adjuvant_therapy_for_surgical_resection_of_hepatocellular_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
ID - 432298
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432298/all/Neoadjuvant_and_adjuvant_therapy_for_surgical_resection_of_hepatocellular_carcinoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
